Skip to main content

Animations

MJFF Publications

3981 - 3990 of 6366 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics
    Journal Name: Expert Review of Neurotherapeutics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/14737175.2021.1923480
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Role of Neuroinflammation in the Establishment of the Neurogenic Microenvironment in Brain Diseases
    Journal Name: Current Tissue Microenvironment Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s43152-021-00028-x
    Citation Count: 2
  • Summary Details
    OPEN
    Title: A high dose tango intervention for people with Parkinson's disease (PwPD)
    Journal Name: Advances in Integrative Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.aimed.2021.07.005
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Data imputation and compression for Parkinson's disease clinical questionnaires
    Journal Name: Artificial Intelligence in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.artmed.2021.102051
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Subtle anomaly detection: Application to brain MRI analysis of de novo Parkinsonian patients
    Journal Name: Artificial Intelligence in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.artmed.2022.102251
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson’s disease and cognition
    Journal Name: Brain, Behavior, and Immunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.bbi.2022.01.005
    Citation Count: 43
  • Summary Details
    OPEN
    Title: The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and function
    Journal Name: Biomedicine & Pharmacotherapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.biopha.2022.113896
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s disease
    Journal Name: Biomedicine & Pharmacotherapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908
    Citation Count: 6
  • Summary Details
    OPEN
    Title: The GBA-370Rec Parkinson's disease risk haplotype harbors a potentially pathogenic variant in the mitochondrial gene SLC25A44
    Journal Name: Molecular Genetics and Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ymgme.2021.03.012
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30449-x
    Citation Count: 251
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.